Skip to main content
NVCT
NASDAQ Life Sciences

$20M Upfront, $1.4B Milestones: Nuvectis Pharma Secures Ex-China Rights to NXP100 & NXP200

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$16.25
Mkt Cap
$438.467M
52W Low
$5.55
52W High
$16.64
52W Position info
193% above low
Off High info
2.3% below high
Rel. Volume info
4.4× avg
Market data snapshot near publication time

NVCT has more than doubled off its 52-week low of $5.55 on elevated volume (4.4× avg).

Summary

Nuvectis Pharma has secured an exclusive ex-China license for two clinical-stage compounds, NXP100 and NXP200, from Haisco Pharmaceutical Group. The agreement includes a $20 million upfront payment and potential development, regulatory, and commercial milestones totaling up to $1.4 billion. This follows an 8-K filing today and a GlobeNewswire report yesterday detailing the same licensing agreement. The $20 million upfront payment is a material investment for the company, which reported a $6.05 million net loss and $6.51 million cash burn in Q1 2026. The deal significantly expands Nuvectis's pipeline in oncology and immunology, offering substantial long-term revenue potential. The agreement is subject to financing conditions to fund development, which will be a key factor to watch.

At the time of this announcement, NVCT was trading at $16.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $438.5M. The 52-week trading range was $5.55 to $16.64. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

NVCT - Latest Insights

NVCT
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $19.42
Real-time Price: $19.24 info
Change: -$0.180 (-0.93%) info
Market Cap: $661.986M info
NVCT
Nov 04, 2026, 8:07 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $19.34
Real-time Price: $19.24 info
Change: -$0.100 (-0.52%) info
Market Cap: $661.986M info
NVCT
Nov 04, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $19.34
Real-time Price: $19.24 info
Change: -$0.100 (-0.52%) info
Market Cap: $661.986M info
NVCT
Oct 26, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $20.05
Real-time Price: $19.24 info
Change: -$0.810 (-4%) info
Market Cap: $661.986M info
NVCT
Sep 24, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $21.70
Real-time Price: $19.24 info
Change: -$2.46 (-11%) info
Market Cap: $661.986M info